1. Home
  2. HUBB vs BNTX Comparison

HUBB vs BNTX Comparison

Compare HUBB & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hubbell Inc

HUBB

Hubbell Inc

HOLD

Current Price

$455.96

Market Cap

23.5B

Sector

Technology

ML Signal

HOLD

Logo BioNTech SE

BNTX

BioNTech SE

HOLD

Current Price

$94.14

Market Cap

24.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HUBB
BNTX
Founded
1888
2008
Country
United States
Germany
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.5B
24.8B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
HUBB
BNTX
Price
$455.96
$94.14
Analyst Decision
Buy
Buy
Analyst Count
7
11
Target Price
$488.43
$137.40
AVG Volume (30 Days)
479.0K
1.6M
Earning Date
02-03-2026
11-03-2025
Dividend Yield
1.25%
N/A
EPS Growth
15.10
N/A
EPS
15.99
N/A
Revenue
$5,686,200,000.00
$3,698,814,972.00
Revenue This Year
$5.89
$2.03
Revenue Next Year
$7.65
N/A
P/E Ratio
$28.52
N/A
Revenue Growth
0.82
3.70
52 Week Low
$299.43
$81.20
52 Week High
$484.26
$129.27

Technical Indicators

Market Signals
Indicator
HUBB
BNTX
Relative Strength Index (RSI) 59.21 42.08
Support Level $424.69 $91.32
Resistance Level $466.67 $93.76
Average True Range (ATR) 11.56 2.16
MACD 1.44 -0.04
Stochastic Oscillator 74.46 34.20

Price Performance

Historical Comparison
HUBB
BNTX

About HUBB Hubbell Inc

Founded in 1888 by Harvey Hubbell, the eponymous company was the conduit through which the pull-chain lamp socket was originally sold. Hubbell has since grown into an electricity transmission and distribution behemoth, housing more than 75 brands that sell components found on power lines, in electrical substations, and in commercial and industrial buildings. The company's primary operations are in the United States, where around 90% of revenue is derived.

About BNTX BioNTech SE

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.

Share on Social Networks: